Bone Metabolism Disorder in Epileptic Children

Area of Science:

• Pediatric Endocrinology
• Metabolic Bone Disease
• Clinical Neurology

Background:

• Epilepsy management frequently involves anti-epileptic drugs.
• These medications can potentially lead to complications affecting bone and vitamin D metabolism.
• Understanding these metabolic disturbances is crucial for comprehensive patient care.

Purpose of the Study:

• To compare bone metabolism disorders in epileptic children versus healthy children.
• To investigate the prevalence of vitamin D deficiency and parathyroid hormone abnormalities.
• To assess potential links between anti-epileptic drug use and metabolic bone complications.

Main Methods:

• A case-control study conducted in Zahedan, Iran (2014-2015).
• Enrolled 40 epileptic children and 40 age-matched healthy controls.
• Assessed serum levels of calcium, phosphorus, parathyroid hormone, magnesium, vitamin D, albumin, and urine creatinine.

Main Results:

• Epileptic children exhibited a significantly higher prevalence of low vitamin D levels (37.5% vs. 12.5%, P=0.010).
• Abnormal parathyroid hormone (PTH) levels were more frequent in epileptic children (13 vs. 2, P=0.002).
• Serum calcium and magnesium levels were comparable between groups; medication count did not impact metabolic parameters.

Conclusions:

• Epileptic children have an increased frequency of hyperparathyroidism and vitamin D deficiency.
• These findings underscore the importance of monitoring bone metabolism in children with epilepsy.
• Further research is warranted to explore preventative strategies against these complications.